Alloimmunization and erythrocyte autoimmunization in transfusion-dependent egyptian thalassemic patients

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 6, 2011, Pages 409-414

  Saied, Dalia A ^a   Kaddah, Ahmed M ^a   Badr Eldin, Reem M ^a   Mohaseb, Safaa S ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b National Blood Transfusion Center   (Egypt)

Author keywords

alloimmunization; autoimmunization; b thalassemia; regular blood transfusion

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; BLOOD GROUP O ANTIGEN; ERYTHROCYTE ANTIBODY; RHESUS D ANTIGEN;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ARTICLE; AUTOIMMUNITY; BETA THALASSEMIA; BLOOD GROUP ABO SYSTEM; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP O; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EGYPTIAN; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AUTOANTIBODIES; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EGYPT; ERYTHROCYTES; FEMALE; HUMANS; INFANT; ISOANTIBODIES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 80051728374     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182208154     Document Type: Article

References (33)

1. Wang LY, Liang DC, Liu HC, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med. 2006;16:200-203.
2. Shamsian SB, Arzanian MT, Shamshiri AR, et al. Frequency of red cell alloimmunization in patients with b-major thalassemia in an Iranian Referral Hospital. Iranian J Pediatr. 2008;18: 149-153. (Pubitemid 351911066)
3. Sadeghian MH, Keramati MR, Badiei Z, et al. Alloimmunization among transfusion-dependant thalassemia patients. Asian J Transfus Sci. 2009;3:95-958.
4. Kyriazi V, Evliati L, Koutsogianni P, et al.: Alloimmunization to erythrocyte antigens in transfusion-dependant patients with haemoglobinopathies: An experience from a Greek blood transfusion service. Haematologica. 2009;94(suppl 2):282. abs 0693.
5. Natukunda B, Schonewille H, Ndugwa C, et al. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion. 2010;50:20-25. [Epub October 10, 2009]
6. Meny G. Review: Transfusing incompatible RBCs-clinical aspects. Immunohematology. 2004;20:161-166. Review. No abstract available. (Pubitemid 39167241)
7. Daniels G. Human Blood Groups. 2nd ed. Oxford: Blackwell publishing Ltd; 2002.
8. Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book. 2nd ed. New York: Elsevier Academic Press; 2004.
9. Santos FWR, Magalhães SMM, et al. Post-transfusion red cell alloimmunization in patients with acute disorders and medical emergencies. Rev Bras Hematol Hemoter. 2007;29:369-372.
10. Singer ST, Wu V, Mignacca R, et al. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood. 2000;96:3369-3373.
11. Ghio M, Contini P, Mazzei C, et al. Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood. 1999;93:17707.
12. Ahmed AM, Hassan NS, Ragab SH, et al. Red cell alloimmunization and autoantibodies in Egyptian transfusion- dependant thalassemia patients. Arch Med Sci. 2010;4: 592-598.
13. Young PP, Uzieblo A, Trulock E, et al. Autoantibody formation after alloimmunization: Are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion. 2004;44:67-72. (Pubitemid 38177138)
14. Ameen R, Al-Shemmari S, Al-Humood S, et al. RBC alloimmunization and autoimmunization among transfusiondependent Arab thalassemia patients. Transfusion. 2003;43: 1604-1610. (Pubitemid 37371832)
15. Mincheff M. Changes in donor leukocytes during blood storage: Implications on post-transfusion immunomodulation and transfusion- associated GVHD. Vox Sang. 1998;74(suppl 2):189-200. (Pubitemid 28379783)
16. Pistillo MP, Tazzari PL, Gaudiano C, et al. Patients with neoplastic and non-neoplastic hematologic diseases acquire CTLA-4 antibodies after blood transfusion. Transfusion. 2001;41:462-469. (Pubitemid 32378097)
17. Schonewille H, Brand A. Alloimmunization to red blood cell antigens after universal leukodepletion: A regional multicentre retrospective study. Br J Haematol. 2005;129:151-156. (Pubitemid 40524063)
18. Gader AG, Al Ghumlas AK, Al-Momen AK. Transfusion medicine in a developing country-alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia. Transfus Apher Sci. 2008;39:199-204. [Epub October 23, 2008].
19. Bhatti FA, Salamat N, Nadeem A, et al. Red cell immunization in beta thalassaemia major. J Coll Physicians Surg Pak. 2004;14:657-660. (Pubitemid 40089950)
20. Noor Haslina MN, Ariffin N, Illuni Hayati I, et al. Red cell immunization in multiply transfused Malay thalassemic patients. Southeast Asian J Trop Med Public Health. 2006;37:1015-1020. (Pubitemid 44844006)
21. Karimi M, Nikrooz P, Kashef S, et al. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran. Int J Lab Hematol. 2007;29:321-326. (Pubitemid 47373619)
22. Castro O, Sandler SG, Houston-Yu P, et al. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: Theoretical and practical implications. Transfusion. 2002;42:684-690.
23. Ho HK, Ha SY, Lam CK, et al. Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients. Blood. 2001;97:3999-4000. No abstract available.
24. Pradhan V, Badakere S, Vasantha K et al. Antibodies to red cells in beta thalassemia major patients receiving multiple transfusions: A short report. Indian J Hematol Blood Transfus. 2001;19:100-101.
25. Noor Haslina MN, Ariffin N, Illuni Hayati I, et al. Red cell autoantibodies among thalassaemia patients in Hospital Universiti Sains Malaysia. Singapore Med J. 2007;48:922.
26. Advani R, Sorenson S, Shinar E, et al. Characterization and comparison of the red blood cell membrane damage in severe human alpha and beta thalassemia. Blood. 1992;79: 1058-1063.
27. Blumberg N, Heal JM, Gettings KF. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion. 2003;43:945-952. (Pubitemid 36753945)
28. Martelli AM, Tazzari PL, Bortul R, et al. Nuclear matrix protein is released from apoptotic white cells during cold (1 to 61C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. Transfusion. 2000;40:169-177. (Pubitemid 30108987)
29. Wiener E, Wanachiwanawin W, Kotipan K, et al. Erythroblast and erythrocyte bound antibodies in alpha and beta thalassemia syndromes. Transfus Med. 1991;1:229-22938.
30. Schonewille H, van de Watering LM, Loomans DS, et al. Red blood cell alloantibodies after transfusion: Factors influencing incidence and specificity. Transfusion. 2006;46:250-256. (Pubitemid 43381762)
31. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion. 1990;30:532-535. (Pubitemid 20244191)
32. Rosse WF, Gallagher D, Kinney TR. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood. 1990;76:1431-1437. (Pubitemid 20342762)
33. Bauer MP, Wiersum-Osselton J, Schipperus M, et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion. 2007;47:2066-2071. (Pubitemid 47623978)